As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...